Neoadjuvant apalutamide (ARN-509) and radical prostatectomy in treatment of intermediate to high risk prostate cancer (NEAR) phase II trial - initial oncological outcomes

被引：0
|
作者：
Yang, X. [1 ]
Aslim, E. J. [1 ]
Ngo, N. T. [1 ]
Khor, L. Y. [1 ]
Chong, T. W. [1 ]
Yuen, J. S. P. [1 ]
Tay, K. J. [1 ]
Ho, H. S. S. [1 ]
Lee, L. S. [1 ]
机构：
[1] Singapore Gen Hosp, Singapore, Singapore
来源：
BJU INTERNATIONAL | 2019年 / 123卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
C-10162
引用
收藏
页码：40 / 40
页数：1
相关论文
共 50 条
  • [41] Phase 1 Trial of Stereotactic Body Radiation Therapy Neoadjuvant to Radical Prostatectomy for Patients With High-Risk Prostate Cancer
    Parikh, Neil R.
    Kishan, Amar U.
    Kane, Nathanael
    Diaz-Perez, Silvia
    Ganapathy, Ekambaram
    Nazarian, Ramin
    Felix, Carol
    Mathis, Colleen
    Bradley, Margaret
    Sachdeva, Ankush
    Wyatt, Bashir
    Basehart, Vince
    Zomorodian, Nazy
    Lin, Lin
    King, Christopher R.
    Kupelian, Patrick A.
    Rettig, Matthew B.
    Steinberg, Michael L.
    Cao, Minsong
    Knudsen, Beatrice S.
    Elashoff, David
    Schaue, Dorthe
    Reiter, Robert E.
    Nickols, Nicholas G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (04): : 930 - 935
  • [42] Clinical-Prostate cancer The impact of very high initial PSA on oncological outcomes after radical prostatectomy for clinically localized prostate cancer
    Tilki, Derya
    Mandel, Philipp
    Karakiewicz, Pierre I.
    Heinze, Alexander
    Huland, Hartwig
    Graefen, Markus
    Knipper, Sophie
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (05) : 379 - 385
  • [43] Brachytherapy for the treatment recurrence prostate cancer after radical prostatectomy. A phase II trial
    Gomez Veiga, F.
    Gomez, I
    Castelo, L.
    Pertega, S.
    Marino, A.
    Fernandez, C.
    Candal, A.
    Casas, J.
    Zarraonaindia, A.
    Pita, S.
    Abal, V
    EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E414 - U909
  • [44] Extended Versus Limited Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate- and High-risk Prostate Cancer: Early Oncological Outcomes from a Randomized Phase 3 Trial
    Lestingi, Jean F. P.
    Guglielmetti, Giuliano B.
    Trinh, Quoc-Dien
    Coelho, Rafael F.
    Pontes, Jose Jr Jr
    Bastos, Diogo A.
    Cordeiro, Mauricio D.
    Sarkis, Alvaro S.
    Faraj, Sheila F.
    Mitre, Anuar, I
    Srougi, Miguel
    Nahas, William C.
    EUROPEAN UROLOGY, 2021, 79 (05) : 595 - 604
  • [45] TITAN: A randomized, double-blind, placebo-controlled, phase 3 trial of apalutamide (ARN-509) plus androgen deprivation therapy (ADT) in metastatic hormone-sensitive prostate cancer (mHSPC)
    Chi, K. N.
    Chowdhury, S.
    Radziszewski, P.
    Lebret, T.
    Ozguroglu, M.
    Sternberg, C.
    Sims, R. B.
    Yu, M.
    Naini, V.
    Darif, M.
    Merseburger, A. S.
    ANNALS OF ONCOLOGY, 2016, 27
  • [46] Neoadjuvant IMC-A12 and combined androgen deprivation with prostatectomy for high-risk prostate cancer: A phase II trial
    Dean, J. P.
    Plymate, S. R.
    Dalkin, B. L.
    Ellis, W. J.
    Lin, D. W.
    Wright, J. L.
    Corman, J. M.
    True, L. D.
    Lange, P. H.
    Montgomery, R. B.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [47] ONCOLOGICAL AND FUNCTIONAL OUTCOMES IN HIGH RISK AND VERY HIGH RISK PROSTATE CANCER PATIENTS RECEIVING ROBOTIC-ASSISTED RADICAL PROSTATECTOMY
    Chen, Wei-Hsin
    JOURNAL OF UROLOGY, 2024, 211 (05): : E952 - E953
  • [48] Adjuvant multimodality treatment in patients with high risk prostate cancer following radical prostatectomy:: Results of a prospective clinical phase-II trial
    Sahi, D.
    Pfister, D.
    Ohlmann, C.
    Thueer, D.
    Heidenreich, A.
    ONKOLOGIE, 2008, 31 : 188 - 189
  • [49] Oncological Outcomes of High-Risk Prostate Cancer Patients between Robot-Assisted Laparoscopic Radical Prostatectomy and Laparoscopic Radical Prostatectomy in Taiwan
    Liao, Chieh-Chun
    Lu, Yu-Chuan
    Tai, Huai-Chin
    Chen, Chung-Hsin
    Pu, Yeong-Shiau
    Huang, Chao-Yuan
    UROLOGICAL SCIENCE, 2018, 29 (01) : 43 - 48
  • [50] Adjuvant multimodality treatment in patients with high risk prostate cancer following radical prostatectomy:: Results of a prospective clinical phase-II trial
    Heidenreich, A.
    Ohlmann, C.
    Pfister, D.
    Thuer, D.
    Engelmann, U. H.
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 57 - 57
12345